{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:54:01Z","timestamp":1790016841571,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z211100002921057"],"award-info":[{"award-number":["Z211100002921057"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222024"],"award-info":[{"award-number":["7222024"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970852"],"award-info":[{"award-number":["81970852"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171110"],"award-info":[{"award-number":["82171110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000962"],"award-info":[{"award-number":["82000962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2504100"],"award-info":[{"award-number":["2022YFC2504100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5\\u2013022"],"award-info":[{"award-number":["2019-I2M-5\\u2013022"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-1-1091"],"award-info":[{"award-number":["2022-1-1091"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.waojou.2024.101009","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:42:45Z","timestamp":1734007365000},"page":"101009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers"],"prefix":"10.1016","volume":"18","author":[{"given":"Yutong","family":"Sima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-9884","authenticated-orcid":false,"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2024.101009_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe--an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib2","first-page":"1","article-title":"Summary health statistics for U.S. adults: national health interview survey, 2012","author":"Blackwell","year":"2014","journal-title":"Vital Health Stat 10"},{"key":"10.1016\/j.waojou.2024.101009_bib3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/all.12874","article-title":"An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011","volume":"71","author":"Wang","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.waojou.2024.101009_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/alr.21931","article-title":"Mortality risk in patients with chronic rhinosinusitis and its association to asthma","volume":"7","author":"Alt","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.waojou.2024.101009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.waojou.2024.101009_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.otc.2016.08.006","article-title":"Refractory chronic rhinosinusitis with nasal polyposis","volume":"50","author":"Hull","year":"2017","journal-title":"Otolaryngol Clin"},{"key":"10.1016\/j.waojou.2024.101009_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.waojou.2024.101009_bib9","first-page":"126","article-title":"Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma","volume":"58","author":"Zhang","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.waojou.2024.101009_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00703-2018","article-title":"Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature","volume":"52","author":"Volmer","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2024.101009_bib11","first-page":"81","article-title":"Predicting difficult-to-treat chronic rhinosinusitis by noninvasive biological markers","volume":"59","author":"Guo","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.waojou.2024.101009_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"van der Veen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib13","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18176\/jiaci.0391","article-title":"Effectiveness of omalizumab in severe allergic asthma and nasal polyposis: a real-life study","volume":"30","author":"Tiotiu","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000514262","article-title":"Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis","volume":"182","author":"Meier","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100702","article-title":"Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers - a real-life prospective study","volume":"15","author":"Zheng","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2024.101009_bib20","first-page":"3","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.waojou.2024.101009_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4168\/aair.2022.14.6.604","article-title":"Chinese guideline on allergen immunotherapy for allergic rhinitis: the 2022 update","volume":"14","author":"Wang","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.waojou.2024.101009_bib22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/13993003.00853-2015","article-title":"A\u00a0summary of the new GINA strategy: a roadmap to asthma control","volume":"46","author":"Reddel","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.waojou.2024.101009_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/alr.22994","article-title":"The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps","volume":"12","author":"Gevaert","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.waojou.2024.101009_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaci.2023.10.024","article-title":"Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation","volume":"153","author":"Nakano","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104883","article-title":"High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in\u00a0vitro studies","volume":"98","author":"Al-Adwi","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.waojou.2024.101009_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2022.10.010","article-title":"Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors","volume":"151","author":"Wang","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","article-title":"Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study","volume":"149","author":"Gevaert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100846","article-title":"Revision surgery versus biologic treatment with omalizumab in recurrent chronic rhinosinusitis with nasal polyps: an analysis of cost-utility and clinical outcomes","volume":"16","author":"Sima","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2024.101009_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and\u00a0safety of monoclonal antibodies and aspirin desensitization for\u00a0chronic rhinosinusitis with nasal polyposis: a\u00a0systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J\u00a0Allergy Clin\u00a0Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib33","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/all.14266","article-title":"Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma","volume":"75","author":"Howarth","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib34","article-title":"Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis","author":"Soyka","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European academy of Allergy and clinical immunology and the American academy of Allergy, asthma & immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2021.03.024","article-title":"Rethinking neutrophils and eosinophils in chronic rhinosinusitis","volume":"148","author":"Delemarre","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","article-title":"A\u00a0substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps","volume":"147","author":"Delemarre","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaci.2019.08.027","article-title":"Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis","volume":"145","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2024.101009_bib39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1165\/rcmb.2005-0303OC","article-title":"Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils","volume":"34","author":"Kikuchi","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.waojou.2024.101009_bib40","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2020.10.010","article-title":"Long-term therapy response to anti-IL-5 biologics in severe asthma-A real-life evaluation","volume":"9","author":"Eger","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2024.101009_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100880","article-title":"Assessment of serum soluble CD40 ligand levels in patients with chronic rhinosinusitis","volume":"17","author":"Liu","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2024.101009_bib42","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cellsig.2013.03.010","article-title":"IgE production in CD40\/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma","volume":"25","author":"Hong","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.waojou.2024.101009_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15321819.2012.683501","article-title":"The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab","volume":"34","author":"Strohner","year":"2013","journal-title":"J\u00a0Immunoassay Immunochem"},{"key":"10.1016\/j.waojou.2024.101009_bib44","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A\u00a0guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.waojou.2024.101009_bib45","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1080\/02770903.2021.1942039","article-title":"High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab","volume":"59","author":"Watanabe","year":"2022","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.waojou.2024.101009_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416149","article-title":"CCL4 regulates eosinophil activation in eosinophilic airway inflammation","volume":"23","author":"Chu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.waojou.2024.101009_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4168\/aair.2022.14.5.465","article-title":"Interpretation of clinical efficacy of biologics in chronic rhinosinusitis with nasal polyps via understanding the local and systemic pathomechanisms","volume":"14","author":"Yang","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.waojou.2024.101009_bib48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2024.101009_bib49","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.2147\/JIR.S322875","article-title":"Necroptosis underlies neutrophilic inflammation associated with the chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"14","author":"Xie","year":"2021","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.waojou.2024.101009_bib50","first-page":"260","article-title":"Elevated serum interleukin-8 level as a preferable biomarker for identifying uncontrolled asthma and glucocorticosteroid responsiveness","volume":"16","author":"Zhang","year":"2017","journal-title":"Tanaffos"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455124001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:35:28Z","timestamp":1778834128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455124001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1939455124001418"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2024.101009","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2024.101009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"101009"}}